Working to Eradicate Gynecologic Cancers

Helen Michael, MD

Professor
Indiana University School of Medicine
Clarian North Medical Center
Indianapolis, IN
USA 46032

Papers:
2 - Scientific Plenary A randomized phase III trial of gemcitabine + docetaxel + bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma (uLMS): a Gynecologic Oncology Group study 143 - Scientific Plenary Prospective validation of pooled clinical prognostic factors in patients with recurrent and advanced cervical cancer: a Gynecologic Oncology Group (GOG) study 144 - Scientific Plenary High-risk patients with recurrent/advanced cervical cancer may derive the most benefit from antiangiogenesis therapy: a Gynecologic Oncology Group (GOG) study